These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12069356)

  • 21. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline.
    Eriksen BO; Småbrekke S; Jenssen TG; Mathisen UD; Norvik JV; Schei J; Schirmer H; Solbu MD; Stefansson VTN; Melsom T
    Hypertension; 2018 Sep; 72(3):594-601. PubMed ID: 30354758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
    Okin PM; Kjeldsen SE; Devereux RB
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of diabetic renal function impairment in the first decade after diagnosed of diabetes mellitus is correlated with high variability of visit-to-visit systolic and diastolic blood pressure: a case control study.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    BMC Nephrol; 2017 Mar; 18(1):99. PubMed ID: 28330451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.
    Davidson MB; Hix JK; Vidt DG; Brotman DJ
    Arch Intern Med; 2006 Apr; 166(8):846-52. PubMed ID: 16636209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease.
    Yokota K; Fukuda M; Matsui Y; Hoshide S; Shimada K; Kario K
    Hypertens Res; 2013 Feb; 36(2):151-7. PubMed ID: 23013884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population.
    Kawabe H; Saito I; Saruta T
    Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats.
    King JN; Strehlau G; Wernsing J; Brown SA
    J Vet Pharmacol Ther; 2002 Oct; 25(5):371-8. PubMed ID: 12423228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4.
    Ford ML; Tomlinson LA; Chapman TP; Rajkumar C; Holt SG
    Hypertension; 2010 May; 55(5):1110-5. PubMed ID: 20212269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
    Perticone F; Maio R; Perticone M; Sciacqua A; Shehaj E; Naccarato P; Sesti G
    Circulation; 2010 Jul; 122(4):379-84. PubMed ID: 20625109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
    Kario K; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K;
    J Hypertens; 2008 Jun; 26(6):1257-65. PubMed ID: 18475166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients.
    Mallamaci F; D'Arrigo G; Tripepi R; Leonardis D; Porto G; Testa A; Abd ElHafeez S; Mafrica A; Versace MC; Provenzano PF; Tripepi G; Mancini P; Zoccali C
    J Hypertens; 2018 Jan; 36(1):119-125. PubMed ID: 28858982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.